(1)
Achievement of Sustained Deep Remission With Adalimumab in a Patient With Both Refractory Ulcerative Colitis and Seronegative Erosive Rheumatoid Arthritis. Reumatismo 2013, 65 (2), 75-78. https://doi.org/10.4081/reumatismo.2013.75.